Catheter-directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis
- 1 October 2017
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 285 (1) , 114-123
Abstract
This study showed the feasibility of endothelial cell therapy with an imaging-guided transcatheter intraportal delivery technique in a porcine model of cirrhosis. PurposeTo demonstrate the feasibility of imaging-guided catheter-directed delivery of endothelial cell therapy in a porcine model of cirrhosis for liver regeneration.Materials and MethodsAfter approval from the institutional animal care and use committee, autologous liver endothelial cells were grown from core hepatic specimens from swine. Cirrhosis was induced in swine by means of transcatheter infusion of ethanol and iodized oil into the hepatic artery. Three weeks after induction of cirrhosis, the swine were randomly assigned to receive autologous cell therapy (endothelial cells, n = 4) or control treatment (phosphate-buffered saline, n = 4) by means of imaging-guided transhepatic intraportal catheterization. Fluorescence-activated cell sorting analysis was performed on biopsy samples 1 hour after therapy. Three weeks after intraportal delivery of endothelial cells, the swine were euthanized and the explanted liver underwent quantitative pathologic examination. Statistical analysis was performed with a...Keywords
Funding Information
- RSNA Research and Education Foundation (RF1407)
This publication has 40 references indexed in Scilit:
- Progress in stem cell‐based therapy for liver diseaseHepatology Research, 2016
- Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocolSystematic Reviews, 2016
- Evidence-based clinical practice guidelines for liver cirrhosis 2015Journal of Gastroenterology, 2016
- Diagnosis and Management of Alcoholic Liver DiseaseJournal of Clinical and Translational Hepatology, 2015
- REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trialBMJ Open, 2015
- Preparing the ground for tissue regeneration: from mechanism to therapyNature Medicine, 2014
- Global burden of alcoholic liver diseasesJournal of Hepatology, 2013
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical TrialsPLOS ONE, 2012